AGP Picks
View all

The California STEM Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.

Press releases published on September 3, 2026

PrimePrix Capital Inc Introduces Upgraded AI Market Analysis Infrastructure
NEW NSF-BACKED PROJECT AIMS TO HELP MIDDLE SCHOOLERS DECIDE WHAT TO TRUST IN THE AGE OF AI
SunStream Global Technologies to Exhibit at Cadence CONNECT: SDA User Conference India 2026
Tenable Uses OpenAI GPT Cyber Models to Help Defenders Inspect Community-Built AI Components
SMM Deal Finder Rebrands as Deeplead, Expanding AI-Powered Outreach to All B2B Sales Teams
The Return of AI Sentient: Story of a Runaway AI Launches as a New Science-Fiction Book and Film Project
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
Proofpoint Brings OpenAI GPT Cyber Models into Security Operations to Help Defenders Investigate Threats Faster
Sophos To Bring OpenAI GPT Cyber Models Into Managed Risk Offering, Helping Defenders Validate Exploit Paths
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
QCI Surpasses 100 Patent Assets in Casino Technology Innovation
DBV Technologies annonce sa participation à plusieurs conférences investisseurs en septembre
DBV Technologies to Participate in Upcoming September Investor Conferences
Tenaya Therapeutics to Participate in Upcoming September Investor Conferences
FingerMotion Announces Non-Binding Three-Party MOU with Lyken.AI and BlueFlare and Provides Update on Alberta Corridor Gas-Supply Discussions
Lianhe Sowell International Group Ltd. Announces Closing of an $11 Million Best-efforts Follow-on Public Offering
Vivani Medical Announces Participation in Upcoming Investor Conferences
Canada’s Drug Agency Issues Recommendation to Reimburse Yorvipath® (palopegteriparatide injection) With Conditions for Eligible Adults With Chronic Hypoparathyroidism
L’Agence des médicaments du Canada recommande le remboursement de Yorvipathᴹᴰ (injection de palopegteriparatide), sous certaines conditions, pour les adultes admissibles atteints d’hypoparathyroïdie chronique.
LB Pharmaceuticals to Participate in Upcoming September Investor Events

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The California STEM Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.